BioSpace News Archive

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that it has made an offer to acquire the assets of Novan, Inc. (Nasdaq: NOVN) (“Novan”) for $15 million in cash and provide up to $15 million in DIP financing to Novan inclusive of a $3 million bridge loan already funded.

BrainStorm Cell Therapeutics Inc. today announced that it has entered into a securities purchase agreement with a single institutional investor for the purchase and sale of 4,054,055 shares of the Company’s common stock and warrants to purchase up to an aggregate of 4,054,055 shares of common stock in a registered direct offering.

Sapphiros, a platform dedicated to building the next generation of consumer diagnostics, is pleased to announce the appointment of Andrew Garfield as its new Vice President of Operations.

Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio”, “Company”, “We” or “Us”) today announced its 2nd positive IMX-110 interim update from the Company’s ongoing Phase 1b/2a IMMINENT-01 (NCT05840835) study of IMX-110 in combination with BeiGene’s anti-PD-1 antibody tislelizumab.

Qilian International Holding Group Ltd, a China-based pharmaceutical and chemical products manufacturer, received notification from The Nasdaq Stock Market LLC, dated July 13, 2023, that the Company is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on The Nasdaq Global Market.

Eli Lilly and Company presented full results from the Phase 3 TRAILBLAZER-ALZ 2 study showing that donanemab significantly slowed cognitive and functional decline in people with early symptomatic Alzheimer’s disease.

Regulatory News: Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announced that it has received $15.3 million as a result of the full disposal of its minority stake in a Chinese biopharmaceutical company.

Xtremity, a premium medical device maker known for developing cutting-edge prosthetic thermoformable socket technology and the creator of the XtremityTT™ Socket System, introduced its new and uniquely crafted flexible inner socket product offering, the XtremityTT™ FLEX.

Guerbet is delighted to announce the success of its teams at the PI-CAI Grand Challenge1, an international challenge organised by a consortium2 of radiology opinion leaders in prostate imaging, urologists and artificial intelligence experts, to compare the performance of artificial intelligence algorithms in the detection of prostate cancer.

The U.S. Food and Drug Administration approved Beyfortus for the prevention of Respiratory Syncytial Virus lower respiratory tract disease in neonates and infants born during or entering their first RSV season, and in children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season.